Dxgen
DxGen is Point-Of-Care (POC) diagnostics company devoted to developing multi-marker for people with diabetes and tuberculosis. Founders and leadership of the company are an experienced team composed of industry leaders with successful track records. Our system, Epithod®616, is the 1st POC analyzer for entire stages of diabetes care to measure both Glycated Albumin and HbA1c. We are committed to applying leading-edge technology in order to provide high quality products.